What works best to protect public health? An international comparison of post-market regulatory risk communication on prescription drugs

什么最能保护公众健康？

• 批准号: 358461
• 负责人: Dormuth Colin R
• 金额: $ 84.43万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2020-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=358461&lang=en
• 关键词: Drug Utilization Research; International Comparison; Key Informant Interviews; Medication Safety; Pharmacoepidemiology; Regulatory Policy; Risk Communication; Systematic Review; Drug Utilization Research; International Comparison; Key Informant Interviews; Medication Safety; Pharmacoepidemiology; Regulatory Policy; Risk Communication; Systematic Review

Medicines provide important health benefits but can also lead to harm, and are a major cause of emergency department visits and hospitalization. Much of this harm is preventable through appropriate use of the safest available treatment option. When new sa

药物提供重要的健康益处，但也可能导致伤害，这是急诊就诊和住院的主要原因。通过适当使用最安全的可用治疗选项，可以预防大部分这种危害。当新SA时